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OBJECTIVE: The aim of this study was to (1) observe the extent to which hemodynamic and glucose measurements
change in patients submitted to a dental procedure with and without a local anesthetic and a vasoconstrictor
(LAVA; 2% mepivacaine with adrenaline 1100,000) and (2) correlate those parameters with the patients’ anxiety
levels.
METHOD: This was an unblinded, random, prospective, and observational study with paired groups. Patients were
evaluated during two different consultations during which they either did or did not receive a local anesthetic/
vasoconstrictor.
RESULTS: Thirty-seven patients ranging in age from 18 to 45 years (mean 30.4 ¡ 5.5 years) were evaluated.
Hemodynamic parameters, including systolic blood pressure, diastolic blood pressure, heart rate, and glucose levels,
did not change significantly in healthy patients, regardless of whether a LAVA was administered during the dental
treatment.
CONCLUSION: The patients’ anxiety statuses neither varied significantly nor showed any correlation with the
studied hemodynamic parameters and glucose levels, regardless of whether local anesthetics were used.
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INTRODUCTION
Under most circumstances, it is impossible to provide
effective dental care without the use of local anesthetics and
vasoconstrictors (LAVA). Although these drug classes have
a history of safety and efficacy, they have the potential to
produce significant toxicity if used carelessly. Whereas local
anesthetics produce peripheral vasodilatation, which con-
tributes to hypotension, even small doses of vasoconstric-
tors can influence cardiovascular function, causing an
increase in cardiac output and stroke volume as well as
alterations in heart rate and arterial blood pressure.1-4
Anxiety may be defined as either a cognitive, emotional,
and physical reaction to a dangerous situation or the
anticipation of a threat.3 Pain and anxiety triggered by
dental treatment can induce the secretion of endogenous
catecholamines. When the situation is combined with LAVA
use, it may increase its undesirable effects on the car-
diovascular system.2,5-7 The physiological effects of such
catecholamines can also include the stimulation of glyco-
genolysis with a consequent increase in the blood level of
glucose;8 however, this issue is controversial.9,10
In clinical practice, dentists try to find the most
comfortable and safe situations for patients. They often
have to decide between using local anesthetics or proceed-
ing with a simple procedure without them. In the latter
circumstance, they must decide which is better for the
patient physiologically and psychologically. The aim of this
study was to (1) observe the extent to which hemodynamic
and glucose measures change in patients submitted to a
dental procedure with and without LAVA administration
(2% mepivacaine with adrenaline 1100,000) and (2) correlate
those parameters with patients’ anxiety levels. Gaining an
understanding of these changes may also allow dentists to
identify situations of increased risk and prevent emergency
situations in clinical practice.
PATIENTS AND METHODS
This is an unblinded prospective and observational study
with paired groups. It was submitted and approved by the
UNOESC/HUST Ethical Committee for Human Research
(number 087/2007). All patients were randomly selected
and invited to participate; however, this study was limited
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to healthy patients between the ages of 18 and 45 years with
the ability to maintain eight hours of fasting. Data collection
was performed in the first hours of the morning. The patients
were evaluated during two different appointments for dental
treatment with a time interval of at least 48 hours. For the first
consultation, the patients (control group) did not receive any
LAVA, whereas the patients (test group) in the second
consultation received a LAVA (2% mepivacaine with adrena-
line 1100,000; Cloridrato de Mepivacaı´na 2% com Epinefrina
1100,000, MepiadreH, DFL, Brazil) for dental treatment at the
maximum amount of 3.2 mL (two cartridges).
On both occasions and before the dental procedure,
patients were asked about the fasting and then rested for 15
minutes. During this period, patients were asked to rate
how anxious they felt about the upcoming procedure using
a numerical scale ranging from 0 to 100 (see Fig. 1).
Immediately before starting the planned dental procedures
for both consultations, baseline measurements of glucose
(GLU), systolic and diastolic arterial blood pressure (SyBP
and DiBP), and heart rate (HR) were taken. A calibrated
wrist digital sphygmomanometer (PowerpackH, MS-808,
Powerpack) certified by INMETRO (National Institute of
Metrology, Standardization and Industrial Quality, Brazil)
was used. A glucometer was utilized for GLU measure-
ments (mg/dL; OneTouchH UltraH, Johnson & Johnson,
Milpitas, California, USA). Fifteen minutes after the initia-
tion of the procedure, new measurements of SyBP, DiBP,
HR and GLU were performed. For the second consultation,
the additional measurement was taken 15 minutes after the
anesthesia procedure with LAVA. With the exception of
GLU, a final measurement of the variables was conducted at
the end of the day’s procedure. Following the procedure, a
snack and fruit juice were offered to the patients to
compensate for the fasting period. The data were analyzed
by BioEstat (version 5.0; Bele´m/Para´, Brazil), with the level
of significance set at p,0.05.
RESULTS
Thirty-seven patients ranging in age from 18 to 45 years
(mean 30.4 ¡ 5.5 years) were evaluated. Nineteen (51.4%)
patients were male. For the first appointment without the
LAVA, the following procedures were performed: dental
restoration (27%), prosthesis (21.6%), dental prophylaxis
(18.9%), endodontic treatment (16.2%), periodontal treat-
ment (10.8%), and others (5.4%). For the second appoint-
ment with the use of LAVA, the following procedures were
performed: dental restoration (67.6%), prosthesis (10.8%),
periodontal treatment (8.1%), endodontic treatment (5.4%),
and others (8.1%).
Patients’ self-reported anxiety levels related to dental
treatment ranged from 5 to 90 (mean 28.9 ¡19.8) during
the first appointment (control) and from 0 to 95 (mean 25.6
¡18.8) during the second (test). For the first and second
appointments, patient anxiety level was not significantly
correlation with GLU level, SyBP, DiBP, and HR in the
established periods of data collection. In addition, self-
reported anxiety level did not vary significantly between
male and female patients or by age, which was dichotomized
as less than and greater than 30 years (median) of age.
No significant changes were observed between appoint-
ments (control and test groups) for all measurements of
GLU levels (see Table 1) and hemodynamic changes,
including SyBP (see Table 2), DiBP (see Table 3), and HR
(see Table 4).
DISCUSSION
Most types of dental treatment can produce discomfort and
pain at some level. Further, pain may influence or be
influenced by anxiety levels related to dental treatment. The
use of a LAVA (injection) can also produce extreme pain and
fear, at least momentarily, in some patients.11,12 On the other
Figure 1 - Numerical scale used to subjectively score patient anxiety level.
Table 1 - Mean, standard deviation (SD), and results of statistical analyses of four glucose measurements taken during
two different appointments for dental treatment with and without LAVA (2% mepivacaine with adrenaline 1100,000)
(n = 37).
Glucose measurements (mg/dL) Mean SD
Paired t-Test within
appointments*
ANOVA* between
all measurements
First appointment (Dental procedure
without anesthesia)
Baseline 90.3 11.8 p = .73 p = .36
Dental procedure with no anesthesia 90.8 12.9
Second appointment (Dental
procedure with anesthesia)
Baseline 92.9 10.4 p = .21
Dental procedure with local anesthesia 94.7 12.1
*p , 0.05
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hand, when a dentist judges that it is possible to go on with a
procedure without the use of a LAVA, patients may also
exhibit discomfort, anxiety, and pain. An ineffective form of
pain control increases the risk of negative patient health
outcomes due to increased levels of endogenous catechola-
mines, particularly norepinephrine, which may increase blood
pressure and heart rate.2,6 The purpose of this study was to
determine if there was a significant correlation between
anxiety levels, hemodynamics, and glucose parameters in
patients undergoing dental treatment, regardless of whether
or not they received a LAVA. No such relationship was found.
Because patients experience adrenergic stimulation under
both sets of circumstances (with and without a LAVA), it is
unclear why their hemodynamic and glucose parameters did
not change significantly. With regard to adrenaline (also
called epinephrine) and adrenergic system stimulation, it
might be that adrenaline has both beta 1 and beta 2 activity.
Beta 1 stimulation tends to cause an increase in blood
pressure, whereas beta 2 stimulation tends to decrease blood
pressure; therefore, it often does not dynamically increase
blood pressure due, in part, to beta 2 activity. A second
possible explanation is that the hemodynamic alterations are
usually short in plasma due to the short adrenaline half-life,
which is approximately less than three minutes. In addition,
when stimulated, the sympathetic nervous system primarily
releases norepinephrine and secondarily releases epinephr-
ine. The effects of both substances on blood pressure have
been described as limited.2,13
Alemany-Martı´nez et al.14 monitored healthy patients
during the surgical removal of lower third molars using 4%
articaine with a vasoconstrictor (adrenaline 1100,000). They
found that the hemodynamic measurements remained
within normal parameters. In that study, all patients
received less than 5.4 mL (3 cartridges) of the LAVA and,
with the exception of the differences between the methods,
these results are consistent with those of the present study,
which also showed no modifications between baseline and
procedure measurements of SyBP, DiBP, and HR. Further,
Table 2 - Mean, standard deviation (SD), and results of statistical analyses of six systolic arterial blood pressure
measurements taken during two different appointments for dental treatment with and without LAVA (2% mepivacaine
with adrenaline 1100,000) (n = 37).
Systolic arterial blood pressure
measurements Mean SD
ANOVA* within
appointment
ANOVA* between
all measurements
First appointment (Dental procedure
without anesthesia)
Baseline 128.1 15.6
During the procedure (15 minutes) 124.3 14.1 p = .54
At the end of the procedure 127.7 12.6 p = .83
Second appointment (Dental
procedure with anesthesia)
Baseline 126.1 15.8
During the procedure (15 minutes after
local anesthesia)
125.3 11.8 p = .86
At the end of the procedure 127.0 11.1
*p , 0.05
Table 3 - Mean, standard deviation (SD), and results of statistical analyses of six diastolic arterial blood pressure
measurements taken during two different appointments for dental treatment with and without LAVA (2% mepivacaine
with adrenaline 1100,000) (n = 37).
Diastolic arterial blood pressure
measurements Mean SD
ANOVA* within
appointment
ANOVA* between
all measurements
First appointment (Dental procedure
without anesthesia)
Baseline 85.7 11.4
During the procedure (15 minutes) 80.2 13.5 p = .10
At the end of the procedure 85.0 11.0 p = .17
Second appointment (Dental
procedure with anesthesia)
Baseline 82.2 11.3
During the procedure (15 minutes after
local anesthesia)
79.8 12.0 p = .62
At the end of the procedure 82.0 10.9
*p , 0.05
Table 4 - Mean, standard deviation (SD), and results of statistical analyses of six heart rate measurements taken during
two different appointments for dental treatment with and without LAVA (2% mepivacaine with adrenaline 1100,000)
(n = 37).
Heart rate measurements Mean SD
ANOVA within
appointment
ANOVA between
all measurements
First appointment (Dental procedure
without anesthesia)
Baseline 71,5 11.7
During the procedure (15 minutes) 69.8 11.3 p = .80
At the end of the procedure 71.0 10.4 p = .97
Second appointment (Dental
procedure with anesthesia)
Baseline 71.7 12.0
During the procedure (15 minutes after
local anesthesia)
70.5 12.6 p = .77
At the end of the procedure 69.8 10.9
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there was no correlation found between hemodynamic
parameters and anxiety in both studies.
Elad et al.5 examined the hemodynamic and electrocar-
diographic responses of cardiovascular patients to two
different local anesthetic solutions with different vasocon-
strictor concentrations (adrenaline 1200,000 versus adrena-
line 1100,000) and found no differences between the
hemodynamic indices of SyBP, DiBP, HR, and blood oxygen
saturation at various time points and intervals between the
two groups. Conrado et al.15 evaluated 54 patients with
coronary disease who underwent dental extraction under
local anesthesia either with or without a vasoconstrictor.
They concluded that the use of anesthesia with 1100,000
epinephrine does not result in additional ischemic risks.
Nevertheless, significant variations in arterial blood pressure
and heart rate were observed in that study in both groups
(with and without a vasoconstrictor). Liau et al.6 found that
patients with severe anxiety and pain upon injection had a
significant increase in HR during anesthetic administration;
however, that increase lasted only 10 minutes. Similar to the
results of the present study, Liau et al.6 did not report any
statistical differences in SyBP and DiBP with one cartridge of
2% lidocaine with 1100,000 epinephrine.
Variations in glucose plasma levels during dental treat-
ment have been the subject of study and controversy in the
literature.9,10,16-18 Tily and Thomas 9 compared the effect of
epinephrine (adrenaline) administration in the dental local
anesthetic solution on blood glucose concentrations in
healthy and diabetic dental patients after extraction. They
observed no significant differences in pre- and post-
operative blood glucose levels. Nakamura et al.10 investi-
gated the changes in blood pressure, plasma catechola-
mines, glucose, and insulin concentrations in 11
normotensive patients during dental surgery and found
that the administration of both local anesthetics and tooth
extraction activates sympathoadrenal outflow, resulting in
increases of the SyBP, HR, plasma epinephrine, and serum
glucose concentrations. They concluded that the adrenaline
concentration increased and reached its peak just after the
administration of local anesthetics, yet the peak of
epinephrine occurred within a time period similar to that
of the increase of the serum glucose level, suggesting that
there is a close relationship between the two variables. The
increase in the glucose level may be small and transient for
healthy patients due to compensatory and regulatory
mechanisms of the body. Although an increase in the mean
glucose levels was observed in this study, it did not reach
statistical or even clinical significance.
CONCLUSION
Hemodynamic parameters, including SyBP, DiBP, HR,
and glucose levels, did not change significantly, regardless
of whether 2% mepivacaine with adrenaline 1100,000
(two cartridges) was used in healthy patients undergoing
dental treatment. The anxiety level of patients neither
varied significantly nor showed any correlation with the
investigated hemodynamic parameters and glucose levels,
regardless of whether local anesthetics were used.
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